Congress returns to Washington next week with some important decisions to make in a short time. One of their immediate priorities should be stabilizing the Health Insurance Marketplaces to protect the millions of Americans who rely on them for health coverage. Policymakers should remove uncertainty about continued funding for cost-sharing reductions. This funding helps cover out-of-pocket costs for lower-income people who purchase coverage through the exchanges. Nearly 60% of marketplace customers rely on these funds – that’s 7 million people, all who earn less than 250% of the federal poverty level. If funding is not continued, consumers will have fewer coverage options. Insurers will exit the marketplaces. Premiums will rise. And hospital resources will be strained as they care for more uninsured Americans. We and other stakeholders agree funding the cost-sharing subsidies is essential to creating stable marketplaces and promoting greater access to coverage. But Congress and the administration have yet to say whether the funding will continue. We urge Congress to take quick action and appropriate the necessary funds.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models. The first proposed…
Headline
The AHA Dec. 19 submitted comments on the Department of Homeland Security’s proposed rule regarding the Public Charge Ground of Inadmissibility, urging the…
Headline
The White House announced Dec. 19 that it reached most-favored-nation deals with nine pharmaceutical companies, aligning their drug prices with the lowest paid…
Headline
The House Dec. 17 passed the Lower Health Care Premiums for All Americans Act (H.R. 6703), legislation to expand association health plans, increase…
Headline
The AHA Dec. 17 urged Elevance Health, which is the parent company of the Anthem brand of health plans, to rescind Anthem’s nonparticipating provider…
Headline
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.  “When…